Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cannapharmarx Inc (OP:CPMD)

0.0032 UNCHANGED
Streaming Delayed Price Updated: 9:42 AM EDT, Aug 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Cannapharmarx Inc

< Previous 1 2 Next >
CannaPharmaRX Expands Cannabis Exports, Projects $1M+ Q3 Revenue
Via ACCESS Newswire
CannapharmaRx Continues into New European Market with First Shipment Completed to Germany
Via ACCESS Newswire
CannapharmaRX Updates on Alberta Facility Progress and International Export Strategy
Via ACCESSWIRE
CannapharmaRx to Complete Additional Shipment in November
Via ACCESSWIRE
CannaPharmaRx Receives Multiple Purchase Orders and Begins Delivery of Product
Via ACCESSWIRE
Q1 2024 Financial Results
Via ACCESSWIRE
CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call
Via ACCESSWIRE
CannapharmaRx Receives First Purchase Order and Begins Shipment of Product
Via ACCESSWIRE
CannaPharmaRx CEO Provides Annual Update Message
Via ACCESSWIRE
CannaPharmaRx to Host Investor Conference Call
Via ACCESSWIRE
CannapharmaRx Pays Off Convertible Notes
Via ACCESSWIRE
CannaPharmaRx Completes First Harvests
Via ACCESSWIRE
CannaPharmaRx to Hold Investor Conference Call
Via ACCESSWIRE
CannaPharmaRx Executes Multi-Year Supply Agreement with ICAN to Create Distribution Network in the Latin Americas
Via ACCESSWIRE
CannaPharmaRx Achieves IMC-GAP and GACP Certifications Completing a Significant Milestone Towards Revenue Acceleration
Via ACCESSWIRE
CannaPharmaRx Finalizes Multi-Million Dollar Israeli Supply Agreement with Cantek
Via ACCESSWIRE
CannaPharmaRx Expands Board of Directors
Via ACCESSWIRE
CannaPharmaRx Appoints Dean Medwid as New CEO
Via ACCESSWIRE
CannaPharmaRx Signs Agreement with Nasha Genetics
Via ACCESSWIRE
CannaPharmaRx Signs Supply Agreement with Y.S.A Holdings for up to $15 Million Annually of Commercial Cannabis
Via ACCESSWIRE
CannaPharmRx, Inc. Completes Purchase of LTB Management, an E- Commerce and Financial Platform Company, and Launches New Corporate Website
Via ACCESSWIRE
CannaPharmRx, Inc. Adds to Revenue Streams by Purchasing E-Commerce and Financial Platform Company
Via ACCESSWIRE
CannaPharmaRx Evaluates Investigation into Market Manipulation and Potentially Illegal Trading of Stock
Via ACCESSWIRE
CannaPharmaRx Releases Year-in-Review Letter to Shareholders and Discusses Revenue Opportunities for 2023
Via ACCESSWIRE
CannaPharmaRx Receives Canada Revenue Agency (CRA) License As Final Step to Bringing Facility Into Production With Annual Revenues of Over $30 Million Expected
Via ACCESSWIRE
Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - December 22, 2022) - Investorideas.com, a leading investor news resource covering cannabis... 
Via Newsfile
Topics Cannabis
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Cannabis
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million
Via ACCESSWIRE
CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million
Calgary, AB – December 21, 2022 – CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today it received its cultivation... 
Via FinancialNewsMedia
Topics Cannabis
Cannabis Cultivation Revenue Continues to Climb as Demand & Usage Grows Across North America
EQNX::TICKER_START (OTCPK:CPMD),(OTCQX:TCNNF),(OTCQX:CURLF),(NASDAQ:TLRY),(NASDAQ:ACB) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Cannabis Derivatives
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.